Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 14507
Country/Region: Zambia
Year: 2017
Main Partner: FHI 360
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USDOD
Total Funding: $4,402,957 Additional Pipeline Funding: $2,000,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $200,000
Care: TB/HIV (HVTB) $400,000
Care: Pediatric Care and Support (PDCS) $40,000
Strategic Information (HVSI) $250,000
Health Systems Strengthening (OHSS) $400,000
Testing: HIV Testing and Counseling (HVCT) $163,396
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $400,000
Treatment: Adult Treatment (HTXS) $1,915,049
Treatment: Pediatric Treatment (PDTX) $634,512
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 45,592
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2018 1
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Male, Negative 2018 1
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2018 6
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2018 56
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2018 19
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2018 86
HTS_TST Service Delivery Point (Community) Index Mod: 25-49, Female, Negative 2018 31
HTS_TST Service Delivery Point (Community) Index Mod: 25-49, Male, Negative 2018 119
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2018 4
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2018 11
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2018 176
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2018 1,935
HTS_TST Service Delivery Point (Facility) ANC: 25-49, Negative 2018 2,699
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2018 8,020
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 40
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2018 11
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 12
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 90
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 84
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 159
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 166
HTS_TST Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 302
HTS_TST Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 582
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 33
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2018 59
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 20
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 12
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 8
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 62
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 86
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 108
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 145
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Female, Negative 2018 207
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Male, Negative 2018 448
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2018 20
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2018 49
HTS_TST Service Delivery Point (Facility) Other PITC: <1, Negative 2018 5
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 62
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 52
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 68
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 302
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 304
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 464
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 532
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 923
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 1,897
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 92
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 195
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2018 20
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2018 12
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2018 13
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2018 60
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2018 119
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2018 124
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2018 209
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Female, Negative 2018 238
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Male, Negative 2018 731
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2018 22
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2018 63
HTS_TST Service Delivery Point (Facility) VMMC: 2018 6
HTS_TST Service Delivery Point (Facility) VMMC: <1, Negative 2018 13
HTS_TST Service Delivery Point (Facility) VMMC: 1-9, Negative 2018 559
HTS_TST Service Delivery Point (Facility) VMMC: 10-14, Negative 2018 1,836
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2018 1,955
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2018 3,284
HTS_TST Service Delivery Point (Facility) VMMC: 25-49, Negative 2018 11,088
HTS_TST Service Delivery Point (Facility) VMMC: 50+, Negative 2018 988
HTS_TST Sum of Test Result disaggregates 2018 3,495
HTS_TST_POS By Test Result: Positive 2018 3,495
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Male, Positive 2018 14
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2018 7
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2018 22
HTS_TST_POS Service Delivery Point (Community) Index Mod: 25-49, Female, Positive 2018 6
HTS_TST_POS Service Delivery Point (Community) Index Mod: 25-49, Male, Positive 2018 29
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2018 15
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2018 168
HTS_TST_POS Service Delivery Point (Facility) ANC: 25-49, Positive 2018 236
HTS_TST_POS Service Delivery Point (Facility) ANC: 50+, Positive 2018 697
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2018 9
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 20
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2018 23
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 41
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 44
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 77
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 139
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2018 13
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2018 11
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2018 12
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 20
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2018 22
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Female, Positive 2018 40
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Male, Positive 2018 84
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2018 9
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 12
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 18
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 17
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 70
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 86
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 121
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 138
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 232
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 460
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 23
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 49
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2018 14
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2018 23
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2018 23
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2018 35
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Female, Positive 2018 43
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Male, Positive 2018 122
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2018 10
HTS_TST_POS Service Delivery Point (Facility) VMMC: 10-14, Positive 2018 19
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2018 19
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2018 33
HTS_TST_POS Service Delivery Point (Facility) VMMC: 25-49, Positive 2018 113
HTS_TST_POS Service Delivery Point (Facility) VMMC: 50+, Positive 2018 10
PMTCT_ART Already on ART at beginning of current pregnancy 2018 583
PMTCT_ART New on ART 2018 477
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 1,060
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 1,007
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 500
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 463
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 16
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 28
PMTCT_STAT By Age (Numerator): : 15-19 2018 2,103
PMTCT_STAT By Age (Numerator): 10-14 2018 192
PMTCT_STAT By Age (Numerator): 20-24 2018 2,934
PMTCT_STAT By Age (Numerator): 25-49 2018 8,717
PMTCT_STAT By known positives: 10-14 2018 10
PMTCT_STAT By known positives: 15-19 2018 104
PMTCT_STAT By known positives: 20-24 2018 145
PMTCT_STAT By known positives: 25-49 2018 432
PMTCT_STAT By new negatives: 10-14 2018 177
PMTCT_STAT By new negatives: 15-19 2018 1,935
PMTCT_STAT By new negatives: 20-24 2018 2,699
PMTCT_STAT By new negatives: 25-49 2018 8,019
PMTCT_STAT By new positives: 10-14 2018 6
PMTCT_STAT By new positives: 15-19 2018 64
PMTCT_STAT By new positives: 20-24 2018 89
PMTCT_STAT By new positives: 25-49 2018 266
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 13,946
PMTCT_STAT_den By Age (Denominator): 10-14 2018 202
PMTCT_STAT_den By Age (Denominator): 15-19 2018 2,214
PMTCT_STAT_den By Age (Denominator): 20-24 2018 3,088
PMTCT_STAT_den By Age (Denominator): 25-49 2018 9,176
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 42
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 88
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 546
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 130
TB_PREV By Age/Sex (Numerator): <15, Female 2018 58
TB_PREV By Age/Sex (Numerator): <15, Male 2018 62
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 2,053
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 1,469
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 3,642
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 3,642
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 58
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 62
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 2,053
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 1,469
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 263
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 574
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 837
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 882
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 277
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 605
TX_CURR Age/Sex: <1 2018 48
TX_CURR Age/Sex: <1-9 2018 625
TX_CURR Age/Sex: 10-14 Female 2018 330
TX_CURR Age/Sex: 10-14 Male 2018 375
TX_CURR Age/Sex: 15-19 Female 2018 550
TX_CURR Age/Sex: 15-19 Male 2018 600
TX_CURR Age/Sex: 20-24 Female 2018 2,475
TX_CURR Age/Sex: 20-24 Male 2018 1,600
TX_CURR Age/Sex: 25-49 Female 2018 19,212
TX_CURR Age/Sex: 25-49 Male 2018 16,003
TX_CURR Age/Sex: 50+ Female 2018 1,900
TX_CURR Age/Sex: 50+ Male 2018 2,250
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 45,968
TX_CURR Sum of age/sex disaggregates 2018 1,150
TX_NEW Breastfeeding status 2018 50
TX_NEW By Age/Sex: <1 2018 40
TX_NEW By Age/Sex: 1-9 2018 50
TX_NEW By Age/Sex: 10-14 Female 2018 26
TX_NEW By Age/Sex: 10-14 Male 2018 26
TX_NEW By Age/Sex: 15-19 Female 2018 100
TX_NEW By Age/Sex: 15-19 Male 2018 100
TX_NEW By Age/Sex: 20-24 Female 2018 300
TX_NEW By Age/Sex: 20-24 Male 2018 2,370
TX_NEW By Age/Sex: 25-49 Female 2018 1,134
TX_NEW By Age/Sex: 25-49 Male 2018 250
TX_NEW By Age/Sex: 50+ Female 2018 100
TX_NEW By Age/Sex: 50+ Male 2018 19
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 4,515
TX_NEW Pregnancy status 2018 300
TX_NEW Sum of Age/Sex disaggregates 2018 4,425
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 37,050
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 33,345
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 584
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 656
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 17,379
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 14,726
TX_PVLS Numerator: Indication: Routine 2018 33,345
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 273
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 396
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 649
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 729
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 19,310
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 16,362
TX_PVLS_den Denominator: Indication: Routine 2018 37,050
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 303
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 439
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 139
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 140
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 3,430
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 2,269
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 5,978
TX_RET Numerator by Status: Breastfeeding 2018 288
TX_RET Numerator by Status: Pregnant 2018 417
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 6,293
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 146
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 148
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 3,610
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 2,389
TX_RET_den Denominator by Status: Breastfeeding 2018 303
TX_RET_den Denominator by Status: Pregnant 2018 439
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 31,397
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 13,187
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 210
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 224
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 7,435
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 5,318
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 500
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 534
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 17,702
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 12,661
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 12,228
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2018 10
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 672
TX_TB_den Denominator: By Screen Result: Negative 2018 18,210
TX_TB_den Denominator: By Screen Result: Positive 2018 13,187
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 12,910
Cross Cutting Budget Categories and Known Amounts Total: $200,000
Human Resources for Health $200,000